Anthony W Kim

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint Innovations in thoracic surgery
    Anthony W Kim
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut 06520, USA
    Curr Opin Anaesthesiol 26:13-9. 2013
  2. doi request reprint Additional pulmonary nodules in the patient with lung cancer: controversies and challenges
    Anthony W Kim
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, 330 Cedar Street, BB 205, New Haven, CT 06520, USA
    Clin Chest Med 32:811-25. 2011
  3. pmc Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Department of Therapeutic Radiology and Radiation Oncology, Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut 06520, USA
    Ann Thorac Surg 94:895-901. 2012
  4. doi request reprint An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
    J Thorac Cardiovasc Surg 143:55-63. 2012
  5. doi request reprint Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, CT 06520, United States
    Lung Cancer 71:186-90. 2011
  6. doi request reprint Lymph node drainage patterns and micrometastasis in lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Semin Thorac Cardiovasc Surg 21:298-308. 2009
  7. pmc Use of new treatment modalities for non-small cell lung cancer care in the Medicare population
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, New Haven, CT 06520, USA
    Chest 143:429-35. 2013
  8. pmc Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale Comprehensive Cancer Center, New Haven, Connecticut, USA
    J Thorac Oncol 7:188-95. 2012
  9. doi request reprint Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 92:233-41; discussion 241-3. 2011
  10. doi request reprint Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base
    Amy C Moreno
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 97:1149-55. 2014

Collaborators

Detail Information

Publications53

  1. doi request reprint Innovations in thoracic surgery
    Anthony W Kim
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut 06520, USA
    Curr Opin Anaesthesiol 26:13-9. 2013
    ....
  2. doi request reprint Additional pulmonary nodules in the patient with lung cancer: controversies and challenges
    Anthony W Kim
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, 330 Cedar Street, BB 205, New Haven, CT 06520, USA
    Clin Chest Med 32:811-25. 2011
    ..This article focuses on the malignant additional pulmonary nodule in the same lobe as the known primary tumor, in a different lobe in the same lung as the known primary tumor, and in the contralateral lung...
  3. pmc Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Department of Therapeutic Radiology and Radiation Oncology, Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut 06520, USA
    Ann Thorac Surg 94:895-901. 2012
    ..However it is unclear how race, clinical, and hospital characteristics affect the surgical approach among patients undergoing resection...
  4. doi request reprint An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
    J Thorac Cardiovasc Surg 143:55-63. 2012
    ..Pneumonectomy after neoadjuvant therapy remains controversial...
  5. doi request reprint Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, CT 06520, United States
    Lung Cancer 71:186-90. 2011
    ..Lack of XOR expression is associated with unfavorable clinical outcomes. The objective of this study was to correlate XOR expression with prognosis in surgically resected non-small cell lung cancer (NSCLC)...
  6. doi request reprint Lymph node drainage patterns and micrometastasis in lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Semin Thorac Cardiovasc Surg 21:298-308. 2009
    ..This manuscript reviews the patterns of lymph node drainage from a historical and current perspective to facilitate an understanding of the existing knowledge with respect to skip metastasis and micrometastasis...
  7. pmc Use of new treatment modalities for non-small cell lung cancer care in the Medicare population
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, New Haven, CT 06520, USA
    Chest 143:429-35. 2013
    ..The adoption of these techniques and their impact on access to cancer care among Medicare beneficiaries with stage I NSCLC are unknown...
  8. pmc Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer
    Michael T Vest
    Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale Comprehensive Cancer Center, New Haven, Connecticut, USA
    J Thorac Oncol 7:188-95. 2012
    ..Studies have suggested that invasive mediastinal staging is underutilized, although practice patterns have not been rigorously evaluated...
  9. doi request reprint Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients
    Anthony W Kim
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 92:233-41; discussion 241-3. 2011
    ..This study evaluated patient survival after neoadjuvant chemoradiation and anatomic pulmonary resections for locoregionally advanced NSCLC...
  10. doi request reprint Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base
    Amy C Moreno
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 97:1149-55. 2014
    ..This retrospective study compares the effect of treatment modalities on survival of patients with large NSCLC with hilar lymph node involvement (T3>7 cmN1)...
  11. doi request reprint Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database
    Amy C Moreno
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut 06520, USA
    J Surg Res 184:10-8. 2013
    ..The objective of this study was to evaluate the effect of surgery in the presence and absence of neoadjuvant radiation (NRT) on survival of patients with T3N0 >7-cm NSCLCs...
  12. doi request reprint Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry
    Usman Ahmad
    Section of Thoracic Surgery, Department of Epidemiology, Yale University School of Public Health, New Haven, Connecticut 06520 8062, USA
    Ann Thorac Surg 94:935-40; discussion 940-1. 2012
    ..To compare outcomes of lung transplantation for advanced BAC, we studied this population in a compulsory, prospectively maintained database...
  13. doi request reprint Lethality of cardiovascular events highlights the variable impact of complication type between thoracoscopic and open pulmonary lobectomies
    Timothy D Law
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 97:993-9. 2014
    ....
  14. doi request reprint Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival
    Gregory A Kuzmik
    Yale School of Medicine, New Haven, CT 06520, USA
    Eur J Cardiothorac Surg 44:e66-70. 2013
    ..The benefits of salvage resection for lung cancer recurrence following high-dose curative-intent chemoradiation therapy are unclear. We assessed survival after salvage lung resection following definitive chemoradiation...
  15. doi request reprint Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base
    Brian N Arnold
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    J Thorac Oncol 11:1121-31. 2016
    ..The objective of this study was to examine treatment patterns and outcomes in young patients with non-small cell lung cancer (NSCLC)...
  16. doi request reprint Adjuvant Chemotherapy for T3 Non-Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe
    Michelle C Salazar
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut
    J Thorac Oncol 11:1090-100. 2016
    ..The survival of patients with T3 tumors and additional tumor nodules in the same lobe treated with and without postoperative chemotherapy was evaluated to understand the role of adjuvant chemotherapy in this setting...
  17. doi request reprint Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer
    Joshua E Rosen
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Conn
    J Thorac Cardiovasc Surg 152:44-54.e9. 2016
    ....
  18. doi request reprint Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery
    Daniel C Thomas
    Yale University School of Medicine, Department of Surgery, Section of Thoracic Surgery, New Haven, CT, USA
    Lung Cancer 103:75-81. 2017
    ..The existing data regarding the management of upstaged SCLC patients and guidelines for their treatment remains sparse. The primary objective was to describe the impact of pathologic upstaging following surgical resection...
  19. doi request reprint Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation
    Charles E Rutter
    Departments of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, USA Electronic address
    Lung Cancer 90:243-8. 2015
    ..The optimal radiotherapy dose in concurrent chemoradiation (CRT) for limited-stage small cell lung cancer (SCLC) is controversial. We compared the effectiveness of several high-dose chemoradiation regimens using a large national dataset...
  20. doi request reprint Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall
    Sarah J Gao
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT
    Clin Lung Cancer . 2016
    ..The present study investigated the effect of adjuvant chemotherapy and radiation on survival among patients undergoing chest wall resection for T3N0 non-small cell lung cancer (NSCLC)...
  21. doi request reprint Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer
    Elyn H Wang
    Elyn H Wang, Christopher D Corso, Charles E Rutter, Henry S Park, Anthony W Kim, Lynn D Wilson, Roy H Decker, and James Byunghoon Yu, Yale School of Medicine Charles E Rutter, Henry S Park, Anthony W Kim, Roy H Decker, and James Byunghoon Yu, Cancer Outcomes, Public Policy, and Effectiveness Research Center at Yale, New Haven, CT and Aileen B Chen, Brigham and Women s Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA
    J Clin Oncol 33:2727-34. 2015
    ..To review trends in the use of postoperative radiotherapy (PORT) for stage II and III incompletely resected non-small-cell lung cancer (NSCLC) and evaluate the association between PORT and survival in such patients...
  22. doi request reprint Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer
    Elyn H Wang
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut
    J Thorac Oncol 10:937-43. 2015
    ..This study examined the impact of facility case volume on overall survival in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive concurrent chemoradiation therapy (CCRT)...
  23. doi request reprint Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes
    Henry S Park
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Ann Thorac Surg 93:372-9. 2012
    ..Some previous analyses comparing VATS vs open lobectomy outcomes have been limited by inaccuracies in patient cohort identification...
  24. doi request reprint Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review
    Ashok Muralidaran
    Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
    J Thorac Cardiovasc Surg 142:1137-42. 2011
    ..The objective of this study was to systematically review the long-term survival associated with the published studies dealing with the performance of lung resections for non-small cell lung cancer using circulatory bypass...
  25. doi request reprint Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer
    Sarah J Gao
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut
    J Thorac Oncol . 2016
    ..However, little data exist to guide the timing of surgery after neoadjuvant therapy. This study examined whether the time interval between neoadjuvant chemoradiation (NCRT) and surgical resection affects overall survival...
  26. doi request reprint The Natural History of Operable Non-Small Cell Lung Cancer in the National Cancer Database
    Joshua E Rosen
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 101:1850-5. 2016
    ..The survival of untreated NSCLC patients in the NCDB was studied to determine the natural history of operable NSCLC...
  27. doi request reprint Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery
    Michelle C Salazar
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut
    JAMA Oncol . 2017
    ..Variable recovery from lung cancer surgery may delay a patient's ability to tolerate adjuvant chemotherapy, yet the urgency of chemotherapy initiation is unclear...
  28. doi request reprint Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase
    Jia Liu
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, CT, USA
    Eur J Cardiothorac Surg 49:596-601. 2016
    ..To determine whether there are differences in survival associated with different treatment modalities among patients with lymph node-negative, very large non-small-cell lung cancers (NSCLCs)...
  29. pmc Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer
    James B Yu
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut
    Cancer 121:2341-9. 2015
    ..The comparative mortalities and toxicities of these treatments for patients of different life expectancies are unknown...
  30. doi request reprint Now or later: evaluating the importance of chemotherapy timing in resectable stage III (N2) lung cancer in the National Cancer Database
    Daniel J Boffa
    Department of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut Electronic address
    Ann Thorac Surg 99:200-8. 2015
    ..It is unclear whether postoperative chemotherapy is as effective as preoperative chemotherapy. Our objective was to determine the survival of resected stage III NSCLC according to the timing of chemotherapy...
  31. doi request reprint Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery
    Jacquelyn G Hancock
    Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 99:406-13. 2015
    ..We examined the survival among incompletely resected NSCLC patients to identify the optimal response to positive NSCLC surgical margins...
  32. doi request reprint Stereotactic body radiotherapy for central lung tumors
    Bryan P Rowe
    Department of Therapeutic Radiology, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut 06520, USA
    J Thorac Oncol 7:1394-9. 2012
    ..The primary purpose of this study was to assess toxicity in patients with central lesions treated with SBRT at our institution, the majority of whom were treated with four fractions...
  33. doi request reprint Hospital volume and outcomes of robot-assisted lobectomies
    Lise N Tchouta
    Yale School of Medicine, Department of Surgery, Section of Thoracic Surgery
    Chest . 2016
    ..The goal of this study was to determine whether or not this volume-outcome relationship translates to robotic-assisted thoracoscopic surgery (RobATS) lobectomy...
  34. doi request reprint Trends in stereotactic body radiation therapy for stage I small cell lung cancer
    John M Stahl
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, United States
    Lung Cancer 103:11-16. 2017
    ..We aimed to report trends in stereotactic body radiation therapy (SBRT) utilization, dose prescriptions, and chemotherapy administration for stage I small cell lung cancer (SCLC) in the United States...
  35. ncbi request reprint The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies
    Oliver K Jawitz
    Department of Surgery, Duke University School of Medicine, Durham, NC, USA
    Eur J Cardiothorac Surg . 2016
    ..There is a lack of published data defining the differential impact of preoperative patient comorbidity on outcomes following VATS and OPEN lobectomies, which would be beneficial for procedure selection and clinical decision-making...
  36. doi request reprint Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database
    Raymond A Jean
    Department of Surgery, Yale School of Medicine, New Haven, CT
    J Am Coll Surg 222:992-1000.e1. 2016
    ..Our goal was to develop a predictive model that identifies how preoperative risk factors and perioperative complications lead to mortality after anatomic pulmonary resections...
  37. doi request reprint A model for predicting prolonged length of stay in patients undergoing anatomical lung resection: a National Surgical Quality Improvement Program (NSQIP) database study
    Matthew R DeLuzio
    Department of Surgery, Yale School of Medicine, New Haven, CT, USA
    Interact Cardiovasc Thorac Surg 23:208-15. 2016
    ....
  38. ncbi request reprint Length of Stay From the Hospital Perspective: Practice of Early Discharge Is Not Associated With Increased Readmission Risk After Lung Cancer Surgery
    Joshua E Rosen
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT
    Ann Surg . 2016
    ..To determine if hospitals that routinely discharge patients early after lobectomy have increased readmissions...
  39. doi request reprint Resection of oligometastatic lung cancer to the pancreas may yield a survival benefit in select patients--a systematic review
    Matthew R DeLuzio
    Department of Surgery, Yale New Haven Hospital, New Haven, CT 06520, USA
    Pancreatology 15:456-62. 2015
    ..To conduct a systematic review of the existing literature regarding surgical therapy for oligometastatic lung cancer to the pancreas...
  40. doi request reprint Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC
    Zain A Husain
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT Electronic address
    Clin Lung Cancer 16:e183-7. 2015
    ..The rate of 30-DM was 2.2%. Age, community treatment center, male sex, and Charlson-Deyo comorbidity score were predictive of higher mortality. Extent of resection was predictive of higher 30-DM in patients aged ‡ 75 years...
  41. doi request reprint Racial disparities in the use of SBRT for treating early-stage lung cancer
    Christopher D Corso
    Yale University School of Medicine, Department of Therapeutic Radiology, New Haven, CT, United States Electronic address
    Lung Cancer 89:133-8. 2015
    ..We undertook a population-based study to evaluate potential racial disparities in the use of SBRT...
  42. doi request reprint Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database
    Christopher D Corso
    Departments of Therapeutic Radiology and Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut and Yale Cancer Center, New Haven, Connecticut
    J Thorac Oncol 10:148-55. 2015
    ..This analysis reassesses the impact of PORT in a modern cohort of patients with particular attention to radiotherapy details...
  43. doi request reprint Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base
    Susan E Combs
    Section of Thoracic Surgery, Yale School of Medicine, New Haven, CT
    J Thorac Oncol 10:316-23. 2015
    ..This study investigates the role of surgical resection in select patients with SCLC, using a national cohort of approximately 2500 resected patients...
  44. doi request reprint Advances in surgical techniques in non-small cell lung cancer
    Anthony W Kim
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut
    Semin Respir Crit Care Med 34:855-66. 2013
    ..These advances, conducted in the setting of multidisciplinary decision making, have resulted in real and palpable advancements for patients with lung cancer. ..
  45. doi request reprint Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?
    Daniel J Boffa
    Department of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
    J Thorac Oncol 5:1779-83. 2010
    ..However, the staging system revision was not designed to evaluate treatment, and attempts to make parallel adjustments in treatment plans may not be justified...
  46. doi request reprint Hospital readmission after pulmonary lobectomy is not affected by surgical approach
    Roland Assi
    Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 99:393-8. 2015
    ..The aim of this study is to identify the predictors of hospital readmission or early unplanned return to clinic within 30 days of discharge after pulmonary lobectomy...
  47. doi request reprint Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer
    Daniel J Boffa
    Department of Thoracic Surgery, Yale University School of Medicine, New Haven, Conn Electronic address
    J Thorac Cardiovasc Surg 148:637-43. 2014
    ..We evaluated complications following anatomic resection of clinical stage I lung cancer by VATS and thoracotomy to clarify the effect of the minimally invasive approach...
  48. doi request reprint Predictors of mortality after surgical management of lung cancer in the National Cancer Database
    Joshua E Rosen
    Department of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 98:1953-60. 2014
    ..We studied surgically managed NSCLC patients in the NCDB to more accurately assess factors that influence perioperative outcomes...
  49. doi request reprint Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States
    Charles E Rutter
    Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, United States Electronic address
    Lung Cancer 85:390-4. 2014
    ..This study characterizes the pervasiveness of this management approach nationally...
  50. doi request reprint Transcervical wedge resection after transcervical extended mediastinal lymphadenectomy
    Anthony W Kim
    From the Section of Thoracic Surgery, Yale School of Medicine, Yale University, New Haven, CT USA and Department of Thoracic Surgery, Pulmonary Hospital, Zakopane, Poland
    Innovations (Phila) 9:327-9. 2014
    ..0 cm) adenocarcinoma. There were no perioperative adverse events with either operation. Transcervical extended mediastinal lymphadenectomy and transcervical lung resections may be performed safely during the same anesthetic setting. ..
  51. doi request reprint Management of clinical stage IIIA primary lung cancers in the National Cancer Database
    Jacqueline Hancock
    Department of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
    Ann Thorac Surg 98:424-32; discussion 432. 2014
    ..In attempt to assess the current state of clinical stage IIIA-cN2 NSCLC in the United States, we examined this controversial cohort in the largest clinical database resource available, the National Cancer Database (NCDB)...
  52. doi request reprint Minimally invasive oesophagectomy more expensive than open despite shorter length of stay
    Anish Dhamija
    Department of Thoracic Surgery, Yale University School of Medicine, New Haven, CT, USA
    Eur J Cardiothorac Surg 45:904-9. 2014
    ..The objective of this study was to compare costs associated with various oesophagectomy approaches for oesophageal cancer...
  53. doi request reprint Experience with thoracoscopic pneumonectomies at a single institution
    Anthony W Kim
    From the Section of Thoracic Surgery, Yale School of Medicine, New Haven, CT USA
    Innovations (Phila) 9:82-6; discussion 86. 2014
    ..The aim of this study was to review a single-institution experience with video-assisted thoracoscopic pneumonectomy (VATP)...